Neupulse offers a discreet wrist‑worn wearable that delivers rhythmic median‑nerve stimulation to modulate brain networks linked to motor control and relaxation, providing a non‑invasive, drug‑free option for stress, anxiety, and tic disorders. The device is self‑administered via an app that tracks usage and offers guidance, and it is built on decades of neuroscience research with ongoing clinical validation.
Funding
Funding not disclosed
Founders
Product
Problem
People with neurological conditions and those seeking everyday mental wellbeing often lack non‑invasive, drug‑free options that can be used independently and fit into daily routines.
Solution
Neupulse offers a discreet wrist‑worn wearable that delivers gentle rhythmic median‑nerve stimulation to influence brain networks associated with motor control and relaxation. The device is designed for self‑administration, allowing users to apply stimulation at any time without medication or clinical supervision. An accompanying mobile app tracks usage and provides guidance, while the underlying technology is grounded in decades of neuroscience research and ongoing clinical trials. Neupulse is positioning the wearable both as a wellness tool for general users and as a precursor to a regulated medical device for tic disorders such as Tourette syndrome. The approach enables users to experience potential calming effects while the company continues to gather real‑world data to support future medical claims.
Target Audience
Primary users are individuals seeking non‑pharmacological support for stress, anxiety, or neurological symptoms, as well as patients with tic disorders and clinicians interested in emerging neuromodulation therapies.
Features
- Wrist‑worn form factor with discreet, comfortable design for continuous daily wear
- Rhythmic median‑nerve electrical pulses delivered at the wrist to modulate brain activity
- App‑driven control and usage tracking, available on iOS and Android
- Non‑invasive, drug‑free stimulation that can be applied on the user’s schedule
- Built on neuroscience research and validated in a UK double‑blind home‑based clinical trial for tic disorders
- Future integration path toward a regulated medical device for neurological conditions